SB 412 establishes Maryland’s Community Forensic Aftercare Program within the Maryland Department of Health. The program monitors two groups: individuals committed to the health department due to being "not criminally responsible" (often called "not guilty by reason of insanity" cases), and people with mental illness or intellectual disability requiring community monitoring under specific legal circumstances. Key mechanisms include creating a community monitoring board to decide on conditional release and out-of-state travel, and requiring licensed social workers ("Program Monitors") to track compliance with court orders and make health recommendations. The bill amends Maryland’s Criminal Procedure and Health codes to implement this program, focusing on safety and structured oversight for these individuals.
SB 411 requires non-state hospitals in Maryland to establish clinical staffing committees with equal representation from management and frontline staff, including nurses, technicians, and other caregivers. These committees must develop evidence-based staffing plans considering patient acuity, staffing gaps, and daily patient needs, which hospitals must implement starting January 1, 2028. Hospitals must annually review these plans, publicly post staffing data on units, and submit annual reports to the Maryland Health Care Commission beginning in 2030. The bill directly affects hospital operations, staffing decisions, and transparency for frontline workers and patients.
HB 624 (Safe Staffing Act of 2026) requires most Maryland hospitals to establish clinical staffing committees with equal management and employee representation, including specific frontline staff like nursing assistants and dietary aides. These committees must develop annual staffing plans considering patient acuity, staffing gaps, and evidence-based standards, then post the plans publicly and update them yearly. Hospitals must implement these plans starting in 2028, allow staff to file complaints about violations, and report annually to the Maryland Health Care Commission beginning in 2030. The law directly affects licensed hospitals and frontline healthcare workers by mandating structured, transparent staffing processes to address patient care needs.
SB 336 extends the deadline for the existing Task Force on Responsible Use of Natural Psychedelic Substances, established by 2024 law, to continue its work studying natural psychedelic substances like psilocybin and mescaline (excluding peyote). The task force, composed of state officials, experts, and community representatives, will study current laws, scientific data on benefits and risks, and barriers to access, then make recommendations for a state access program and legal changes. This extension allows the task force to finalize its report on creating equitable access to these substances and transitioning away from criminal penalties for nonviolent uses. The bill does not change current laws but prolongs the study period to inform future policy decisions.
SB 205 codifies federal mental health parity requirements into Maryland law, requiring health insurance carriers to comply with the Paul Wellstone and Pete Domenici Mental Health Parity Act. It mandates carriers to collect and report data on access to mental health and substance use disorder benefits, explain differences in care access, and undergo comparative analyses of nonquantitative treatment limitations. The Maryland Insurance Commissioner gains authority to review carrier reports and address noncompliance. This bill directly affects all health insurance carriers operating in Maryland, ensuring their coverage aligns with federal parity standards for mental health and substance use disorder benefits. It clarifies enforcement mechanisms without creating new benefit requirements.
HB 280 codifies Maryland’s health insurance requirements for mental health and substance use disorder coverage to align with federal parity laws. It requires health insurers to collect and report data on access to these services, explain differences in coverage rules, and comply with federal standards for equal treatment. The Maryland Insurance Commissioner will review insurer reports and address noncompliance. This bill directly affects health insurance companies and their policyholders seeking mental health or substance use disorder care.
SB 385 (The Vax Act) requires Maryland’s Secretary of Health to issue evidence-based recommendations for immunizations, screenings, and preventive services, aligning with guidance from major medical organizations like the CDC and U.S. Preventive Services Task Force. It expands pharmacists’ authority to administer vaccines (including those recommended by CDC or the Secretary) to patients aged 3+ after completing specific training and certification, while mandating health insurers to cover these services without cost-sharing. The bill also repeals outdated pertussis-related provisions and updates reporting requirements for pharmacists. This directly affects pharmacists, health insurers, and patients seeking preventive care, aiming to improve access to vaccinations and screenings.
HB 637 ("The Vax Act") requires Maryland's Secretary of Health to issue science-based recommendations for immunizations, screenings, and preventive services using guidance from major medical organizations like the CDC and American Academy of Pediatrics. It expands pharmacists' authority to administer flu, COVID-19, and emergency vaccines to patients aged 3 and older (previously limited to 18+ for some vaccines) after completing specific training. The bill also mandates that health insurance plans cover these recommended services without cost-sharing for patients. This directly affects pharmacists, health insurers, and Maryland residents seeking preventive care, particularly children and adults needing routine vaccinations.
HB 498 removes an existing exemption that allowed intermediate care facilities providing substance use disorder treatment to change bed capacity without a certificate of need. It specifically targets facilities offering "medically managed residential substance use disorder treatment services," requiring them to file 45 days' written notice with the health commission before operating or expanding. The commission must then review and approve these changes based on whether they align with the state health plan, improve service efficiency, and serve the public interest. This bill directly affects facilities providing residential substance use treatment by adding a review process for bed capacity changes or new operations, replacing the previous exemption.
HB 797 prohibits employers from discriminating against fire and rescue public safety employees who use medical cannabis, provided they have a valid written certification from a licensed healthcare provider under Maryland's medical cannabis program. The bill modifies existing law to clarify that an employer cannot take adverse employment actions (like termination or denial of promotion) solely due to medical cannabis use, as long as the employee meets the state's certification requirements. It updates definitions in Maryland law to ensure fire and rescue employees qualify for the same protections as other medical cannabis patients under the existing program. The law does not override workplace safety rules or require employers to accommodate cannabis use during work hours.
